Aspirin adherence, depression and one-year prognosis after acute coronary syndrome

Psychotherapy and Psychosomatics

Volumn 80, Issue 5, 2011, Pages 316-318

  Rieckmann, Nina ^a   Burg, Matthew M ^b,f   Kronish, Ian M ^c   Chaplin, William F ^e   Schwartz, Joseph E ^b   Davidson, Karina W ^b,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c Division of General Internal Medicine   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e ST JOHN'S UNIVERSITY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ACUTE CORONARY SYNDROME; ADULT; CORRELATION ANALYSIS; DEPRESSION; DRUG MONITORING; FEMALE; HOSPITAL PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS;

ACUTE CORONARY SYNDROME; ASPIRIN; DEPRESSION; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PROGNOSIS; RECURRENCE;

EID: 79959663224     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000323168     Document Type: Letter

References (19)

1. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, Fauerbach JA, Bush DE, Ziegelstein RC: Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21: 30-38.
2. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66: 802-813. (Pubitemid 39552862)
3. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, van den Brink RH, van den Berg MP: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814-822. (Pubitemid 39552863)
4. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW: Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794-811.
5. Hulten E, Jackson JL, Douglas K, George S, Villines TC: The effect of early, intensive statin therapy on acute coronary syndrome: a metaanalysis of randomized controlled trials. Arch Intern Med 2006; 166: 1814-1821. (Pubitemid 44455162)
6. Rasmussen JN, Chong A, Alter DA: Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007; 297: 177-186. (Pubitemid 46089734)
7. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS: Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842-1847. (Pubitemid 44455166)
8. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS: Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995; 14: 88-90.
9. Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, Vorchheimer D, Davidson KW: Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006; 152: 922-927. (Pubitemid 44632939)
10. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-2107. (Pubitemid 30482715)
11. Gehi A, Haas D, Pipkin S, Whooley MA: Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 2005; 165: 2508-2513. (Pubitemid 41720013)
12. Rieckmann N, Gerin W, Kronish IM, Burg MM, Chaplin WF, Kong G, Lespérance F, Davidson KW: Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 2006; 48: 2218-2222. (Pubitemid 44855442)
13. Davidson KW, Burg MM, Kronish IM, Shimbo D, Dettenborn L, Mehran R, Vorchheimer D, Clemow L, Schwartz JE, Lespérance F, Rieckmann N: Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry 2010; 67: 480-488.
14. Beck AT, Steer RA: Manual for the Beck Depression Inventory. San Antonio, Psychological Corporation, 1993.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. (Pubitemid 17055592)
16. Carney RM, Freedland KE, Miller GE, Jaffe AS: Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002; 53: 897-902. (Pubitemid 35282619)
17. Skala JA, Freedland KE, Carney RM: Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry 2006; 51: 738-745. (Pubitemid 44656504)
18. Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, Ali S, Dowray S, Na B, Feldman MD, Schiller NB, Browner WS: Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-2388.
19. Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M: Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 2010; 79: 323-325.